GT Biopharma Inc reports results for the quarter ended in March - Earnings Summary

GT Biopharma

25/05/2021 10:58

* GT Biopharma Inc  GTBP.OQ  reported a quarterly adjusted loss
of $1.83​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 24
cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* GT Biopharma Inc shares had risen by 123.5% this quarter and
gained 112.1% so far this year.
* The company reported a quarterly loss of $29.68 million.
* Wall Street's median 12-month price target for GT Biopharma
Inc is $25.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 25 at 09:58 a.m. GMT.
​All figures in US dollars